<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Cognitive behavioral therapy for insomnia in adults</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Cognitive behavioral therapy for insomnia in adults</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Cognitive behavioral therapy for insomnia in adults</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Jennifer L Martin, PhD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Ruth Benca, MD, PhD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">April F Eichler, MD, MPH</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Oct 05, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H2634896151"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Cognitive behavioral therapy for insomnia (CBT-I) is a multicomponent treatment for chronic insomnia disorder that aims to identify and target the multiple cognitive and behavioral factors that lead to the chronic nature of disrupted sleep. CBT-I is the mainstay of nonpharmacologic therapy for insomnia disorder and is preferred over medications as first-line therapy for chronic insomnia.</p><p>This topic reviews the conceptual basis, components, and delivery of CBT-I and other behavioral treatments for insomnia in adults. An overview of the treatment of insomnia and pharmacologic therapies for insomnia are presented separately. (See  <a class="medical medical_review" href="/d/html/97867.html" rel="external">"Overview of the treatment of insomnia in adults"</a> and  <a class="medical medical_review" href="/d/html/97868.html" rel="external">"Pharmacotherapy for insomnia in adults"</a>.)</p><p class="headingAnchor" id="H327030747"><span class="h1">THEORETICAL FRAMEWORK</span><span class="headingEndMark"> — </span>Insomnia disorder, once conceptualized as a common secondary symptom of other conditions, is now viewed as an independent sleep disorder worthy of clinical attention, even in the context of comorbidities [<a href="#rid1">1,2</a>]. Two core conceptual frameworks underlie the rationale for treatment of insomnia disorder with cognitive behavioral therapies (CBTs). The theories are not mutually exclusive and provide a conceptual framework for the development and treatment of insomnia.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Predisposing, precipitating, and perpetuating factors</strong> – One theory suggests that insomnia develops in some individuals as a result of predisposing, precipitating, and perpetuating factors  (<a class="graphic graphic_table graphicRef122747" href="/d/graphic/122747.html" rel="external">table 1</a>) [<a href="#rid3">3</a>]. Predisposing factors are conceptualized as risk factors and may include genetic risk, early life experiences, and some chronic comorbidities. Precipitating events are life events that lead to an acute disruption in sleep, such as an illness, injury, or symptom exacerbation; a change in social factors, such as living situation or marital status; or a traumatic event. Multicomponent CBT-I directly addresses perpetuating factors, which are believed to be the source of ongoing, chronic sleep-related problems.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Conditioned arousal and sleep-related hyperarousal</strong> – A second theory is the development of a classically conditioned response to the sleep environment such that the bed and bedroom are associated with anxiety, alertness, and arousal rather than with sleepiness or sleep onset  (<a class="graphic graphic_figure graphicRef122799" href="/d/graphic/122799.html" rel="external">figure 1</a>). Stimulus control therapy is used to "unlearn" the association between the sleep environment and sleeplessness. (See <a class="local">'Stimulus control therapy'</a> below.)</p><p></p><p class="headingAnchor" id="H3797238991"><span class="h1">BASELINE EVALUATION</span></p><p class="headingAnchor" id="H695666439"><span class="h2">Diagnostic confirmation</span><span class="headingEndMark"> — </span>Insomnia disorder is a clinical diagnosis based on patient interview and history. The International Classification of Sleep Disorders, Third Edition, Text Revision (ICSD-3-TR)  (<a class="graphic graphic_table graphicRef117710" href="/d/graphic/117710.html" rel="external">table 2</a>) [<a href="#rid4">4</a>] and the Diagnostic and Statistical Manual for Mental Disorders, Fifth Edition (DSM-5) [<a href="#rid5">5</a>] use similar diagnostic criteria for insomnia disorder. (See  <a class="medical medical_review" href="/d/html/7676.html" rel="external">"Evaluation and diagnosis of insomnia in adults"</a>.)</p><p>Clinicians should establish that the patient meets diagnostic criteria for insomnia disorder and rule out other conditions that may have similar clinical presentations but a different underlying etiology, such as insufficient sleep, circadian rhythm sleep-wake phase disorders, sleep apnea, and other sleep disorders, in preparation for behavioral treatments. One of the key goals of the evaluation is to distinguish between insufficient sleep that results from behavioral factors (eg, watching television late at night, then rising early to commute to work), versus an inability to sleep despite having a sufficient opportunity to sleep  (<a class="graphic graphic_table graphicRef122800" href="/d/graphic/122800.html" rel="external">table 3</a>). Insomnia must also be distinguished from delayed sleep phase and other circadian rhythm disorders. (See  <a class="medical medical_review" href="/d/html/7676.html" rel="external">"Evaluation and diagnosis of insomnia in adults", section on 'Differential diagnosis'</a>.)</p><p class="headingAnchor" id="H3637890352"><span class="h2">Patient eligibility and interest</span><span class="headingEndMark"> — </span>Most patients who meet diagnostic criteria for insomnia disorder are appropriate for cognitive and behavioral interventions. CBT-I requires patients to be engaged with a multisession approach, and patients must be interested in a nonpharmacologic approach to their sleep problems.</p><p>While the number of mental health providers trained in the delivery of CBT-I continues to grow, an additional challenge is that some geographic regions still have few skilled providers able to deliver CBT-I [<a href="#rid6">6</a>]. In these situations, patients may benefit from self-guided treatments (eg, online, mobile applications, or printed). (See <a class="local">'Alternative delivery modalities'</a> below.)</p><p>There is some evidence that patients prefer nonpharmacologic approaches, such as CBT-I, over medications; however, medications are still commonly used in clinical practice. Women and younger individuals tend to have even stronger preferences for behavioral treatments over pharmacologic treatments of psychiatric disorders in general [<a href="#rid7">7</a>].</p><p>In a study examining the acceptability of pharmacologic treatments and nonpharmacologic treatments of insomnia among women veterans, nonpharmacologic treatments of insomnia were rated as "very acceptable" significantly more often than pharmacologic treatments for insomnia [<a href="#rid8">8</a>]. Another study, which investigated preferences among hospitalized patients on a geriatric assessment unit, found that 82 percent of participants felt nondrug alternatives were healthier than medications in managing sleep difficulties [<a href="#rid9">9</a>]. This may indicate a potential mismatch between patient preference for treatment and treatments they are given within routine clinical care.</p><p class="headingAnchor" id="H1839738545"><span class="h2">Precautions</span><span class="headingEndMark"> — </span>There are a few clinical situations in which the use of CBT-I may be inappropriate, and precautions should be taken. In some cases, CBT-I can be modified to improve safety. These precautions are generally based on the potential adverse effects of short-term sleep time reduction that can result from implementation of sleep restriction therapy. These conditions include:</p><p class="bulletIndent1"><span class="glyph">●</span>Patients with poorly controlled seizure disorder</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Patients with untreated bipolar disorder who have a history of a manic and/or hypomanic episode or who have had manic symptoms triggered by sleep loss in the past</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Patients who have experienced an acute change in health status, such as an illness, accident, or surgery</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Patients who are excessively sleepy during the day (eg, due to severe, untreated sleep apnea)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Patients who may experience increased occupational risks as a result of increased sleepiness, such as transportation industry workers or individuals in occupations that require sustained alertness</p><p></p><p>In most instances, CBT-I can be adapted for individuals who are not candidates for sleep restriction therapy by using other components of CBT-I to improve sleep quality (eg, sleep hygiene, sleep/wake schedule stabilization, cognitive therapy approaches). Sleep restriction therapy and stimulus control therapy can also be modified and used in some cases.</p><p class="headingAnchor" id="H706604380"><span class="h2">Helping patients access CBT-I</span><span class="headingEndMark"> — </span>Since healthcare providers who deliver CBT-I typically have specialized training, it may be necessary to seek out these providers specifically. There are two main resources to consider:</p><p class="bulletIndent1"><span class="glyph">●</span>The Society for Behavioral Sleep Medicine (SBSM) lists providers who are members of the organization by geographic region within and outside of the United States and provides accreditation to training programs. Individuals who are Diplomates of the American Board of Behavioral Sleep Medicine are also listed on the <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.behavioralsleep.org%2F&amp;token=h7Ird6MEQJ0ciS3wlIS74wbcbXTpVR2Nfo4SBRkMGv9wOfJR%2BklihrknVUv65mC3&amp;TOPIC_ID=97869" target="_blank">SBSM website</a>. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Accredited sleep disorders center through the American Academy of Sleep Medicine (AASM) are required to provide comprehensive care for insomnia disorder, either within the center or through referrals. Accredited centers can be searched by United States zip code on the <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fmembers.aasm.org%2FAASMMembers%2FAccreditation%2FAccredited-Facility-Directory.aspx%3F_gl%3D1*gkp91g*_gcl_au*MTA0ODI4MzgwMC4xNjk0NDYwNzg1%26_ga%3D2.98393885.369405808.1695757008-1341046009.1684780623&amp;token=UrF2R93EFZ36DleesbT53qQvMNmEhx2UHwUXIaIezbF0ZCY7zbvjyjN%2B%2BoU5l263xRIBnXMHZ92baXjMUZaXEM%2Fqmzv2PnCoPaXVAiQ9l7Uf%2FoA6rGRPK2H2AY0eKbQaKGTFkUh2rvqyT3XCa2pHOWdp3d5p2OU4iKUCnmfX748XKF%2BBghkOr1x33sb4uuC%2FRqZ9kJeqI5u%2BRXKuQ1Nq5%2B7hHUeBdy1fQjDdn3KAb0k%3D&amp;TOPIC_ID=97869" target="_blank">AASM website</a>.</p><p></p><p>Some patients may be interested in self-directed app-based treatments. Two free options are:</p><p class="bulletIndent1"><span class="glyph">●</span><a class="external" href="/external-redirect?target_url=https%3A%2F%2Fmobile.va.gov%2Fapp%2Finsomnia-coach&amp;token=UqPIHL52Jk7c70PbcztP6sWvdeisieGkl66JTjgmOVkV7%2BsLxY20RncwR9DuvEeprwC1JCwUsNIWoeWxLU0oqw%3D%3D&amp;TOPIC_ID=97869" target="_blank">Insomnia Coach</a>, which is available through the Department of Veterans Affairs </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><a class="external" href="/external-redirect?target_url=https%3A%2F%2Fmobile.va.gov%2Fapp%2Fcbt-i-coach&amp;token=UqPIHL52Jk7c70PbcztP6pGW2KIQi%2FUernTweThmSnkVYNf8pRQPfBfzc3onSMIx&amp;TOPIC_ID=97869" target="_blank">CBT-I Coach</a>, which is available to assist individuals who are engaged in CBT-I with a treating healthcare provider</p><p></p><p class="headingAnchor" id="H4125084328"><span class="h1">COMPONENTS OF THERAPY</span><span class="headingEndMark"> — </span>CBT-I is a multicomponent treatment that is comprised of behavioral and cognitive components. </p><p class="headingAnchor" id="H4167874887"><span class="h2">Sleep education</span><span class="headingEndMark"> — </span>CBT-I requires patients to engage in a number of behaviors that are counterintuitive, and treatment begins with education about insomnia and sleep. This education then provides a framework for recommendations associated with the cognitive and behavioral strategies that follow. Education components typically cover all of the following:</p><p class="bulletIndent1"><span class="glyph">●</span>The "3 P's" model of how insomnia develops (see <a class="local">'Theoretical framework'</a> above)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The two-process model of sleep regulation: sleep drive and circadian rhythms  (<a class="graphic graphic_figure graphicRef103729" href="/d/graphic/103729.html" rel="external">figure 2</a>) [<a href="#rid10">10</a>] (see  <a class="medical medical_review" href="/d/html/97844.html" rel="external">"Overview of circadian rhythm sleep-wake disorders", section on 'Functions of the circadian system'</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Cognitive and physical arousal and the need for reducing arousal near bedtime </p><p></p><p class="headingAnchor" id="H1028837085"><span class="h2">Sleep restriction therapy</span><span class="headingEndMark"> — </span>Sleep restriction therapy is designed to address the maladaptive behavioral pattern adopted by many insomnia patients that leads to extended time in bed, and therefore, to extended periods of wakefulness during the night [<a href="#rid11">11,12</a>]. This approach is a recommended treatment for insomnia disorder [<a href="#rid13">13,14</a>] and is a multistep process carried out over multiple sessions.</p><p>During the treatment, the patient is asked to maintain a daily sleep diary  (<a class="graphic graphic_table graphicRef87134" href="/d/graphic/87134.html" rel="external">table 4</a> and <a class="graphic graphic_table graphicRef87859" href="/d/graphic/87859.html" rel="external">table 5</a>) that is used to calculate total sleep time and sleep efficiency (ie, the percent of time the patient is asleep out of the time they are in bed intending to sleep) [<a href="#rid15">15</a>]. The steps for implementation of sleep restriction therapy are shown in the table  (<a class="graphic graphic_table graphicRef122801" href="/d/graphic/122801.html" rel="external">table 6</a>).</p><p class="headingAnchor" id="H1395166011"><span class="h2">Sleep compression</span><span class="headingEndMark"> — </span>Sleep compression is an alternative to sleep restriction therapy in patients with a contraindication to acute sleep loss, such as active bipolar disorder of poorly controlled epilepsy (see <a class="local">'Precautions'</a> above). Sleep compression is the inverse of sleep restriction therapy. The steps involved in sleep compression are shown in the table  (<a class="graphic graphic_table graphicRef122802" href="/d/graphic/122802.html" rel="external">table 7</a>).</p><p class="headingAnchor" id="H3240121028"><span class="h2">Stimulus control therapy</span><span class="headingEndMark"> — </span>Stimulus control therapy is based on the theory of conditioned insomnia and is designed to help the patient relearn an association between the sleep environment and rapid sleep onset [<a href="#rid16">16</a>], and it is supported as a treatment for insomnia [<a href="#rid14">14</a>]. Stimulus control involves a set of instructions that are designed to eliminate situations in which the sleeper is in bed struggling with sleep and increase the frequency of falling asleep quickly in bed. Instructions for stimulus control are shown in the table  (<a class="graphic graphic_table graphicRef122803" href="/d/graphic/122803.html" rel="external">table 8</a>).</p><p class="headingAnchor" id="H2119871825"><span class="h2">Sleep hygiene</span><span class="headingEndMark"> — </span>Sleep hygiene interventions involve targeting behavioral habits that negatively impact sleep. It is important to note that sleep hygiene alone is not considered an effective treatment for insomnia disorder, although this approach is typically incorporated into CBT-I [<a href="#rid17">17,18</a>].</p><p>Sleep hygiene can be implemented in a variety of ways; however, core principles address spending an appropriate amount of time in bed, dietary and substance use habits, and improving the sleep environment  (<a class="graphic graphic_table graphicRef122804" href="/d/graphic/122804.html" rel="external">table 9</a>). Many of these recommendations are incorporated into other components of CBT-I (eg, having a regular rise time, avoiding naps) as part of sleep restriction and/or stimulus control approaches.</p><p class="headingAnchor" id="H1589112370"><span class="h2">Cognitive therapy</span><span class="headingEndMark"> — </span>Cognitive therapy involves identifying and addressing maladaptive thoughts that lead to negative emotions [<a href="#rid19">19,20</a>]. In the case of insomnia disorder, thoughts and beliefs about sleep can increase arousal near bedtime and delay or prevent sleep. Thoughts and beliefs can also increase the likelihood of engaging in unhelpful behaviors such as extending time in bed to try to catch up on sleep based on the belief that "casting a wide net" will lead to fewer daytime symptoms.</p><p class="headingAnchor" id="H1400556611"><span class="h2">Counter-arousal measures, including relaxation</span><span class="headingEndMark"> — </span>Relaxation-based strategies were some of the earliest treatments used for insomnia disorder [<a href="#rid21">21</a>]. Two common approaches are progressive muscle relaxation (PMR) and diaphragmatic breathing. Relaxation therapies are commonly incorporated into CBT-I treatments as a way to reduce arousal near bedtime. Neither approach is typically used as a stand-alone therapy.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Progressive muscle relaxation</strong> – PMR involves learning to elicit a physical relaxation response by tensing and relaxing different muscle groups in the body, focusing on a relaxed state. Patients are instructed to practice this skill regularly and obtain mastery before applying the skills at bedtime. (See  <a class="medical medical_review" href="/d/html/16851.html" rel="external">"Acute procedural anxiety and specific phobia of clinical procedures in adults: Treatment overview"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Diaphragmatic breathing</strong> – Diaphragmatic breathing  (<a class="graphic graphic_table graphicRef126994" href="/d/graphic/126994.html" rel="external">table 10</a>) is a technique for breathing that also elicits a relaxation response by balancing oxygen and carbon dioxide levels. Anxiety is associated with faster, shallow breathing, which increases oxygen levels in the blood in preparation for a "fight or flight" response. As with PMR, patients are instructed to practice diaphragmatic breathing before using it to facilitate relaxation in bed when attempting to sleep.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Mindfulness</strong> – Mindfulness-based approaches have also been used to address arousal in insomnia patients. These approaches involve contact with the present moment and engagement with experiences and emotions. They are sometimes combined with behavioral techniques, such as stimulus control and sleep restriction, and sometimes used separately to treat insomnia [<a href="#rid22">22</a>]. In one trial, mindfulness-based cognitive therapy (MBCT) was superior a sleep education control for insomnia outcomes at two- and five-month follow-up, although these differences were not sustained at the eight-month follow-up visit [<a href="#rid23">23</a>].</p><p></p><p class="headingAnchor" id="H1678618578"><span class="h1">SEQUENCING AND COMBINATION WITH MEDICATIONS</span><span class="headingEndMark"> — </span>A preference for CBT-I or other behavioral therapies over medication as initial therapy has been endorsed in clinical practice guidelines of the American Academy of Sleep Medicine [<a href="#rid24">24</a>], the British Association for Psychopharmacology [<a href="#rid25">25</a>], the American College of Physicians [<a href="#rid26">26,27</a>], and the European Sleep Research Society [<a href="#rid28">28</a>].</p><p>Hypothetically, combining CBT-I with medications is appealing, as medications may quickly improve sleep quality, while the full benefits of CBT-I may not be realized for several weeks. However, there is some evidence that the use of hypnotic medications can negatively impact outcomes of CBT-I [<a href="#rid29">29</a>], and medications do not appear to enhance treatment benefits of CBT-I alone [<a href="#rid30">30</a>].</p><p>When CBT-I is not sufficiently effective, clinical practice guidelines support the use of medications as an adjunctive treatment [<a href="#rid26">26</a>]. In such cases, patients and providers should discuss the risks and benefits of medications and develop a plan for monitoring potential adverse effects. (See  <a class="medical medical_review" href="/d/html/97868.html" rel="external">"Pharmacotherapy for insomnia in adults"</a>.)</p><p class="headingAnchor" id="H1726477932"><span class="h1">TREATMENT DURATION</span><span class="headingEndMark"> — </span>CBT-I is a brief treatment, typically lasting four to eight sessions. A dose-response study showed that the greatest benefit was received with four or eight sessions as compared with one or two sessions [<a href="#rid31">31</a>]. There are other approaches that use brief interventions focused on the behavioral elements that may result in improvements in two to four sessions. (See <a class="local">'Brief behavioral treatment approaches'</a> below.)</p><p class="headingAnchor" id="H3719764262"><span class="h1">EFFICACY OF THERAPY</span></p><p class="headingAnchor" id="H3763849362"><span class="h2">Traditional one-on-one delivery</span><span class="headingEndMark"> — </span>There is moderate-quality evidence that multicomponent CBT-I results in clinically significant improvement in chronic insomnia in patients with [<a href="#rid32">32,33</a>] and without [<a href="#rid34">34-37</a>] comorbid medical and psychiatric disorders [<a href="#rid38">38,39</a>]. Improvement in insomnia symptoms typically occurs gradually over the course of CBT-I delivery, and the benefits tend to be durable beyond the end of treatment [<a href="#rid39">39</a>].</p><p>A 2021 meta-analysis by the American Academy of Sleep Medicine (AASM) included 49 randomized trials of CBT-I versus a control condition (eg, wait list, sleep hygiene education, placebo) in nearly 4000 patients with chronic insomnia [<a href="#rid38">38</a>]. In-person, one-on-one CBT-I was the most common delivery method (21 trials with a total of 1174 patients). Outcomes demonstrating improvements that exceeded clinical significance thresholds compared with control included:</p><p class="bulletIndent1"><span class="glyph">●</span>Insomnia remission rate (absolute difference 33 percentage points higher for CBT-I versus control)</p><p class="bulletIndent1"><span class="glyph">●</span>Treatment responder rate (45 percentage points higher for CBT-I versus control)</p><p class="bulletIndent1"><span class="glyph">●</span>Insomnia severity index scores (large effect size for the difference between CBT-I versus control)</p><p></p><p>Improvements in sleep latency (13 minutes shorter for CBT-I versus control), sleep quality (small to moderate effect size for the difference between CBT-I versus control), wake after sleep onset by sleep diary (19 minutes lower for CBT-I versus control), and total sleep time by sleep diary (9.7 minutes longer for CBT-I versus control) were statistically significant but did not meet clinical significance thresholds. The overall quality of the evidence was rated as moderate due to modest effect sizes on some critical outcomes (imprecision) and lack of blinding in some trials (risk of bias). A separate meta-analysis found moderate improvements in quality of life associated with CBT-I, particularly in patients without comorbid medial or psychiatric disorders [<a href="#rid40">40</a>].</p><p>Although traditionally delivered in person, CBT-I can also be delivered using a telemedicine format. In randomized noninferiority trials, insomnia outcomes are similar for face-to-face and telemedicine-delivered CBT-I, and the therapeutic alliance is maintained despite the remote format [<a href="#rid41">41,42</a>].</p><p class="headingAnchor" id="H882061520"><span class="h2">Alternative delivery modalities</span><span class="headingEndMark"> — </span>There is also moderate-quality evidence to support the efficacy of CBT-I using alternative delivery methods such as group CBT-I [<a href="#rid43">43</a>], telephone-based CBT-I [<a href="#rid44">44,45</a>], and internet-based CBT-I [<a href="#rid46">46-55</a>]. These modalities may help to overcome some of the access, economic, and cultural barriers that exist for one-on-one CBT-I.</p><p>The 2021 AASM meta-analysis included data from 28 randomized trials of CBT-I using various alternative delivery methods versus a control condition in nearly 3000 adults with chronic insomnia [<a href="#rid38">38</a>]. Outcomes for each delivery method were not analyzed separately due to heterogeneity across the studies.</p><p>One critical access barrier to CBT-I is the availability of skilled providers, and alternative delivery modalities may increase access to individuals who are unable to receive care in a one-on-one format in their local area. As an example, one trial enrolled 1711 patients with self-reported insomnia (out of nearly 10,000 screened) and randomly assigned them to receive a six-session digital CBT-I program or a control condition (access to sleep hygiene education material on the study website) [<a href="#rid54">54</a>]. Approximately half of patients in the intervention arm completed all six sessions of digital CBT-I, and 20 percent did not complete any sessions. Compared with controls in an intent-to-treat analysis, patients assigned to CBT-I showed greater improvement in a range of self-reported health outcomes, including small improvements in functional health and psychological well-being and larger gains in sleep-related quality of life and insomnia symptoms. However, specific sleep data were not reported.</p><p>Additional studies are needed to compare alternative delivery methods directly with face-to-face CBT-I [<a href="#rid56">56</a>]. In a small trial comparing face-to-face and clinician-guided online CBT-I with a wait-list control in 90 patients with insomnia, both delivery methods performed significantly better than the wait-list control, but face-to-face CBT-I was associated with larger treatment effects and better depression and anxiety outcomes than online delivery [<a href="#rid57">57</a>].</p><p>A caveat of the available literature is that the patient populations studied using alternative modalities differ in important ways, and there are different access barriers depending upon how treatment is offered. For example, telehealth or online programs may be desirable when travel to a treatment site is a barrier, but face-to-face sessions may be preferable when access to technology is a challenge, or when the patient has sensory impairments that make engagement with online content difficult (eg, visual or hearing impairment).</p><p class="headingAnchor" id="H1953279337"><span class="h2">CBT-I to facilitate discontinuation of hypnotics</span><span class="headingEndMark"> — </span>CBT-I is commonly used to address insomnia symptoms in patients who are attempting to discontinue sedative-hypnotic medication use. Treating the underlying insomnia can help decrease anticipatory anxiety and fear of rebound insomnia, which are common among patients attempting to stop medications [<a href="#rid58">58,59</a>].</p><p>Several small trials support the role of CBT-I in combination with hypnotic-taper interventions to improve the likelihood of a successful taper [<a href="#rid60">60-62</a>]. A systematic review identified eight such randomized trials in 482 adults [<a href="#rid63">63</a>]. CBT-I plus gradual medication taper improved the likelihood of hypnotic discontinuation at study completion compared with gradual taper alone (45 versus 27 percent; RR 1.68, 95% CI 1.19-2.39). Subjective sleep outcomes also improved more with CBT-I. Long-term (12-month) outcomes pooled from four trials were similar but did not reach statistical significance.</p><p class="headingAnchor" id="H3413102926"><span class="h1">BRIEF BEHAVIORAL TREATMENT APPROACHES</span><span class="headingEndMark"> — </span>There is a growing body of evidence to support the use of briefer, behaviorally-focused treatments for insomnia disorder (eg, brief behavioral treatment for insomnia [BBTI]) in adults [<a href="#rid38">38,64-69</a>]. These interventions are typically shorter in length compared with CBT-I and contain a subset of the behavioral components, such as stimulus control  (<a class="graphic graphic_table graphicRef122803" href="/d/graphic/122803.html" rel="external">table 8</a>), abbreviated sleep restriction therapy  (<a class="graphic graphic_table graphicRef122801" href="/d/graphic/122801.html" rel="external">table 6</a>), and sleep hygiene  (<a class="graphic graphic_table graphicRef122804" href="/d/graphic/122804.html" rel="external">table 9</a>).</p><p>Although supporting evidence is of lower quality compared with traditional CBT-I, BBTI is an acceptable alternative for patients who prefer the shorter format or when resources do not allow for CBT-I [<a href="#rid38">38,39</a>].</p><p>A variety of interventions delivered face-to-face or remotely by clinicians with varied levels of expertise have been studied. One method that may be clinically feasible and cost effective is to train nurses or advanced practice providers to deliver sleep restriction therapy as a behavioral approach. In an open-label randomized trial in England involving 642 adults with insomnia disorder recruited from 35 general practices, four sessions of nurse-delivered sleep restriction therapy improved patient-reported insomnia severity scores compared with a sleep hygiene booklet alone [<a href="#rid69">69</a>]. At six-month follow-up, 42 percent of patients in the treatment arm met criteria for a clinical treatment response, compared with 17 percent in the control group. Other smaller trials have shown similar benefits from other nurse-delivered BBTI approaches [<a href="#rid64">64,65</a>].</p><p class="headingAnchor" id="H2126653446"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/d/html/113803.html" rel="external">"Society guideline links: Insomnia in adults"</a>.)</p><p class="headingAnchor" id="H308988434"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)</p><p class="bulletIndent1"><span class="glyph">●</span>Basics topic (see  <a class="medical medical_basics" href="/d/html/16177.html" rel="external">"Patient education: Insomnia (The Basics)"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Beyond the Basics topics (see  <a class="medical medical_patient" href="/d/html/7717.html" rel="external">"Patient education: Insomnia (Beyond the Basics)"</a> and  <a class="medical medical_patient" href="/d/html/7718.html" rel="external">"Patient education: Insomnia treatments (Beyond the Basics)"</a>)</p><p></p><p class="headingAnchor" id="H3012251719"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Overview</strong> – Cognitive behavioral therapy for insomnia (CBT-I) is the mainstay of nonpharmacologic therapy for insomnia disorder and is preferred to medications as first-line therapy for chronic insomnia. (See  <a class="medical medical_review" href="/d/html/97867.html" rel="external">"Overview of the treatment of insomnia in adults"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Theoretical framework</strong> – CBT-I aims to identify and target factors that sustain insomnia and correct maladaptive, conditioned arousal to the sleep environment. (See <a class="local">'Theoretical framework'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Baseline evaluation</strong> – Basic requirements for CBT-I include a clinical diagnosis of insomnia disorder  (<a class="graphic graphic_table graphicRef117710" href="/d/graphic/117710.html" rel="external">table 2</a>) and a patient who is interested in a nonpharmacologic approach to their sleep problems. (See <a class="local">'Baseline evaluation'</a> above.)</p><p></p><p class="bulletIndent1">For the sleep restriction component of therapy, caution is required in patients with poorly controlled seizures or other comorbidities that would increase the potential for adverse effects of short-term sleep time reduction. (See <a class="local">'Precautions'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Components of therapy</strong> – CBT-I is a multicomponent treatment typically consisting of sleep education, sleep restriction therapy  (<a class="graphic graphic_table graphicRef122801" href="/d/graphic/122801.html" rel="external">table 6</a>), sleep compression  (<a class="graphic graphic_table graphicRef122802" href="/d/graphic/122802.html" rel="external">table 7</a>), stimulus control therapy  (<a class="graphic graphic_table graphicRef122803" href="/d/graphic/122803.html" rel="external">table 8</a>), sleep hygiene  (<a class="graphic graphic_table graphicRef122804" href="/d/graphic/122804.html" rel="external">table 9</a>), cognitive therapy, and counter-arousal measures, including relaxation  (<a class="graphic graphic_table graphicRef126994" href="/d/graphic/126994.html" rel="external">table 10</a>). (See <a class="local">'Components of therapy'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Treatment duration</strong> – CBT-I is a brief treatment, typically lasting four to eight sessions. Even shorter behavioral approaches are an acceptable alternative for patients who prefer the shorter format or when resources do not allow for CBT-I. (See <a class="local">'Treatment duration'</a> above and <a class="local">'Brief behavioral treatment approaches'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Efficacy of therapy</strong> – In randomized trials, multicomponent CBT-I results in clinically significant improvements in sleep outcomes and quality of life in patients with and without comorbid medical and psychiatric disorders. (See <a class="local">'Traditional one-on-one delivery'</a> above.)</p><p></p><p class="bulletIndent1">In addition to traditional face-to-face delivery, accumulating evidence supports alternative delivery methods such as group CBT-I, internet-based CBT-I, and brief behavioral treatments. (See <a class="local">'Alternative delivery modalities'</a> above and <a class="local">'Brief behavioral treatment approaches'</a> above.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Stepanski EJ, Rybarczyk B. Emerging research on the treatment and etiology of secondary or comorbid insomnia. Sleep Med Rev 2006; 10:7.</a></li><li><a class="nounderline abstract_t">National Institutes of Health. National Institutes of Health State of the Science Conference statement on Manifestations and Management of Chronic Insomnia in Adults, June 13-15, 2005. Sleep 2005; 28:1049.</a></li><li class="breakAll">Spielman A, Glovinsky PB. The varied nature of insomnia. In: Case Studies in Insomnia, Hauri PJ (Ed), Plenum Press, New York 1991.</li><li class="breakAll">American Academy of Sleep Medicine. International Classification of Sleep Disorders, 3rd ed, text revision, American Academy of Sleep Medicine, 2023.</li><li class="breakAll">American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 5th ed, American Psychiatric Association, Arlington, VA 2013.</li><li><a class="nounderline abstract_t">Baglioni C, Altena E, Bjorvatn B, et al. The European Academy for Cognitive Behavioural Therapy for Insomnia: An initiative of the European Insomnia Network to promote implementation and dissemination of treatment. J Sleep Res 2020; 29:e12967.</a></li><li><a class="nounderline abstract_t">McHugh RK, Whitton SW, Peckham AD, et al. Patient preference for psychological vs pharmacologic treatment of psychiatric disorders: a meta-analytic review. J Clin Psychiatry 2013; 74:595.</a></li><li><a class="nounderline abstract_t">Culver NC, Song Y, Kate McGowan S, et al. Acceptability of Medication and Nonmedication Treatment for Insomnia Among Female Veterans: Effects of Age, Insomnia Severity, and Psychiatric Symptoms. Clin Ther 2016; 38:2373.</a></li><li><a class="nounderline abstract_t">Azad N, Byszewski A, Sarazin FF, et al. Hospitalized patients' preference in the treatment of insomnia: pharmacological versus non-pharmacological. Can J Clin Pharmacol 2003; 10:89.</a></li><li><a class="nounderline abstract_t">Borbély AA. A two process model of sleep regulation. Hum Neurobiol 1982; 1:195.</a></li><li><a class="nounderline abstract_t">Spielman AJ, Saskin P, Thorpy MJ. Treatment of chronic insomnia by restriction of time in bed. Sleep 1987; 10:45.</a></li><li><a class="nounderline abstract_t">Maurer LF, Espie CA, Omlin X, et al. Isolating the role of time in bed restriction in the treatment of insomnia: a randomized, controlled, dismantling trial comparing sleep restriction therapy with time in bed regularization. Sleep 2020; 43.</a></li><li><a class="nounderline abstract_t">Morin CM, Hauri PJ, Espie CA, et al. Nonpharmacologic treatment of chronic insomnia. An American Academy of Sleep Medicine review. Sleep 1999; 22:1134.</a></li><li><a class="nounderline abstract_t">Chesson AL Jr, Anderson WM, Littner M, et al. Practice parameters for the nonpharmacologic treatment of chronic insomnia. An American Academy of Sleep Medicine report. Standards of Practice Committee of the American Academy of Sleep Medicine. Sleep 1999; 22:1128.</a></li><li><a class="nounderline abstract_t">Carney CE, Buysse DJ, Ancoli-Israel S, et al. The consensus sleep diary: standardizing prospective sleep self-monitoring. Sleep 2012; 35:287.</a></li><li class="breakAll">Bootzin RR, Epstein D, Wood JM. Stimulus control instructions. In: Studies in Insomnia, Hauri P (Ed), Plenum Press, New York 1991. p.19.</li><li><a class="nounderline abstract_t">Hauri PJ. Insomnia. Clin Chest Med 1998; 19:157.</a></li><li><a class="nounderline abstract_t">Stepanski EJ, Wyatt JK. Use of sleep hygiene in the treatment of insomnia. Sleep Med Rev 2003; 7:215.</a></li><li class="breakAll">Beck AT, Rush AJ, Shaw BF, Emery G. Cognitive Theory of Depression, The Guilford Press, New York 1981.</li><li><a class="nounderline abstract_t">Ballesio A, Bacaro V, Vacca M, et al. Does cognitive behaviour therapy for insomnia reduce repetitive negative thinking and sleep-related worry beliefs? A systematic review and meta-analysis. Sleep Med Rev 2021; 55:101378.</a></li><li><a class="nounderline abstract_t">Nicassio PM, Boylan MB, McCabe TG. Progressive relaxation, EMG biofeedback and biofeedback placebo in the treatment of sleep-onset insomnia. Br J Med Psychol 1982; 55:159.</a></li><li><a class="nounderline abstract_t">Ong JC, Ulmer CS, Manber R. Improving sleep with mindfulness and acceptance: a metacognitive model of insomnia. Behav Res Ther 2012; 50:651.</a></li><li><a class="nounderline abstract_t">Wong SY, Zhang DX, Li CC, et al. Comparing the Effects of Mindfulness-Based Cognitive Therapy and Sleep Psycho-Education with Exercise on Chronic Insomnia: A Randomised Controlled Trial. Psychother Psychosom 2017; 86:241.</a></li><li><a class="nounderline abstract_t">Schutte-Rodin S, Broch L, Buysse D, et al. Clinical guideline for the evaluation and management of chronic insomnia in adults. J Clin Sleep Med 2008; 4:487.</a></li><li><a class="nounderline abstract_t">Wilson SJ, Nutt DJ, Alford C, et al. British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders. J Psychopharmacol 2010; 24:1577.</a></li><li><a class="nounderline abstract_t">Qaseem A, Kansagara D, Forciea MA, et al. Management of Chronic Insomnia Disorder in Adults: A Clinical Practice Guideline From the American College of Physicians. Ann Intern Med 2016; 165:125.</a></li><li><a class="nounderline abstract_t">Brasure M, Fuchs E, MacDonald R, et al. Psychological and Behavioral Interventions for Managing Insomnia Disorder: An Evidence Report for a Clinical Practice Guideline by the American College of Physicians. Ann Intern Med 2016; 165:113.</a></li><li><a class="nounderline abstract_t">Riemann D, Baglioni C, Bassetti C, et al. European guideline for the diagnosis and treatment of insomnia. J Sleep Res 2017; 26:675.</a></li><li><a class="nounderline abstract_t">Morin CM, Colecchi C, Stone J, et al. Behavioral and pharmacological therapies for late-life insomnia: a randomized controlled trial. JAMA 1999; 281:991.</a></li><li><a class="nounderline abstract_t">Beaulieu-Bonneau S, Ivers H, Guay B, Morin CM. Long-Term Maintenance of Therapeutic Gains Associated With Cognitive-Behavioral Therapy for Insomnia Delivered Alone or Combined With Zolpidem. Sleep 2017; 40.</a></li><li><a class="nounderline abstract_t">Edinger JD, Wohlgemuth WK, Radtke RA, et al. Dose-response effects of cognitive-behavioral insomnia therapy: a randomized clinical trial. Sleep 2007; 30:203.</a></li><li><a class="nounderline abstract_t">Taylor DJ, Pruiksma KE. Cognitive and behavioural therapy for insomnia (CBT-I) in psychiatric populations: a systematic review. Int Rev Psychiatry 2014; 26:205.</a></li><li><a class="nounderline abstract_t">Wu JQ, Appleman ER, Salazar RD, Ong JC. Cognitive Behavioral Therapy for Insomnia Comorbid With Psychiatric and Medical Conditions: A Meta-analysis. JAMA Intern Med 2015; 175:1461.</a></li><li><a class="nounderline abstract_t">Epstein DR, Sidani S, Bootzin RR, Belyea MJ. Dismantling multicomponent behavioral treatment for insomnia in older adults: a randomized controlled trial. Sleep 2012; 35:797.</a></li><li><a class="nounderline abstract_t">Okajima I, Komada Y, Inoue Y. A meta-analysis on the treatment effectiveness of cognitive behavioral therapy for primary insomnia. Sleep Biol Rhythms 2011; 9:24.</a></li><li><a class="nounderline abstract_t">Mitchell MD, Gehrman P, Perlis M, Umscheid CA. Comparative effectiveness of cognitive behavioral therapy for insomnia: a systematic review. BMC Fam Pract 2012; 13:40.</a></li><li><a class="nounderline abstract_t">van Straten A, van der Zweerde T, Kleiboer A, et al. Cognitive and behavioral therapies in the treatment of insomnia: A meta-analysis. Sleep Med Rev 2018; 38:3.</a></li><li><a class="nounderline abstract_t">Edinger JD, Arnedt JT, Bertisch SM, et al. Behavioral and psychological treatments for chronic insomnia disorder in adults: an American Academy of Sleep Medicine systematic review, meta-analysis, and GRADE assessment. J Clin Sleep Med 2021; 17:263.</a></li><li><a class="nounderline abstract_t">Edinger JD, Arnedt JT, Bertisch SM, et al. Behavioral and psychological treatments for chronic insomnia disorder in adults: an American Academy of Sleep Medicine clinical practice guideline. J Clin Sleep Med 2021; 17:255.</a></li><li><a class="nounderline abstract_t">Alimoradi Z, Jafari E, Broström A, et al. Effects of cognitive behavioral therapy for insomnia (CBT-I) on quality of life: A systematic review and meta-analysis. Sleep Med Rev 2022; 64:101646.</a></li><li><a class="nounderline abstract_t">Arnedt JT, Conroy DA, Mooney A, et al. Telemedicine versus face-to-face delivery of cognitive behavioral therapy for insomnia: a randomized controlled noninferiority trial. Sleep 2021; 44.</a></li><li><a class="nounderline abstract_t">Gehrman P, Gunter P, Findley J, et al. Randomized Noninferiority Trial of Telehealth Delivery of Cognitive Behavioral Treatment of Insomnia Compared to In-Person Care. J Clin Psychiatry 2021; 82.</a></li><li><a class="nounderline abstract_t">Koffel EA, Koffel JB, Gehrman PR. A meta-analysis of group cognitive behavioral therapy for insomnia. Sleep Med Rev 2015; 19:6.</a></li><li><a class="nounderline abstract_t">Arnedt JT, Cuddihy L, Swanson LM, et al. Randomized controlled trial of telephone-delivered cognitive behavioral therapy for chronic insomnia. Sleep 2013; 36:353.</a></li><li><a class="nounderline abstract_t">Bastien CH, Morin CM, Ouellet MC, et al. Cognitive-behavioral therapy for insomnia: comparison of individual therapy, group therapy, and telephone consultations. J Consult Clin Psychol 2004; 72:653.</a></li><li><a class="nounderline abstract_t">Vincent N, Lewycky S. Logging on for better sleep: RCT of the effectiveness of online treatment for insomnia. Sleep 2009; 32:807.</a></li><li><a class="nounderline abstract_t">Ritterband LM, Thorndike FP, Gonder-Frederick LA, et al. Efficacy of an Internet-based behavioral intervention for adults with insomnia. Arch Gen Psychiatry 2009; 66:692.</a></li><li><a class="nounderline abstract_t">van Straten A, Emmelkamp J, de Wit J, et al. Guided Internet-delivered cognitive behavioural treatment for insomnia: a randomized trial. Psychol Med 2014; 44:1521.</a></li><li><a class="nounderline abstract_t">Holmqvist M, Vincent N, Walsh K. Web- vs. telehealth-based delivery of cognitive behavioral therapy for insomnia: a randomized controlled trial. Sleep Med 2014; 15:187.</a></li><li><a class="nounderline abstract_t">Ritterband LM, Thorndike FP, Ingersoll KS, et al. Effect of a Web-Based Cognitive Behavior Therapy for Insomnia Intervention With 1-Year Follow-up: A Randomized Clinical Trial. JAMA Psychiatry 2017; 74:68.</a></li><li><a class="nounderline abstract_t">Zachariae R, Lyby MS, Ritterband LM, O'Toole MS. Efficacy of internet-delivered cognitive-behavioral therapy for insomnia - A systematic review and meta-analysis of randomized controlled trials. Sleep Med Rev 2016; 30:1.</a></li><li><a class="nounderline abstract_t">van der Zweerde T, van Straten A, Effting M, et al. Does online insomnia treatment reduce depressive symptoms? A randomized controlled trial in individuals with both insomnia and depressive symptoms. Psychol Med 2019; 49:501.</a></li><li><a class="nounderline abstract_t">Cheng P, Luik AI, Fellman-Couture C, et al. Efficacy of digital CBT for insomnia to reduce depression across demographic groups: a randomized trial. Psychol Med 2019; 49:491.</a></li><li><a class="nounderline abstract_t">Espie CA, Emsley R, Kyle SD, et al. Effect of Digital Cognitive Behavioral Therapy for Insomnia on Health, Psychological Well-being, and Sleep-Related Quality of Life: A Randomized Clinical Trial. JAMA Psychiatry 2019; 76:21.</a></li><li><a class="nounderline abstract_t">Zhou ES, Ritterband LM, Bethea TN, et al. Effect of Culturally Tailored, Internet-Delivered Cognitive Behavioral Therapy for Insomnia in Black Women: A Randomized Clinical Trial. JAMA Psychiatry 2022; 79:538.</a></li><li><a class="nounderline abstract_t">Espie CA. "Stepped care": a health technology solution for delivering cognitive behavioral therapy as a first line insomnia treatment. Sleep 2009; 32:1549.</a></li><li><a class="nounderline abstract_t">Lancee J, van Straten A, Morina N, et al. Guided Online or Face-to-Face Cognitive Behavioral Treatment for Insomnia: A Randomized Wait-List Controlled Trial. Sleep 2016; 39:183.</a></li><li><a class="nounderline abstract_t">Salzman C. The APA Task Force report on benzodiazepine dependence, toxicity, and abuse. Am J Psychiatry 1991; 148:151.</a></li><li><a class="nounderline abstract_t">Sweetman A, Lovato N, Li Chai-Coetzer C, Saini B. Deprescribing long-term use of benzodiazepines in primary care practice: where to next? Sleep 2023; 46.</a></li><li><a class="nounderline abstract_t">Morin CM, Bastien C, Guay B, et al. Randomized clinical trial of supervised tapering and cognitive behavior therapy to facilitate benzodiazepine discontinuation in older adults with chronic insomnia. Am J Psychiatry 2004; 161:332.</a></li><li><a class="nounderline abstract_t">Belleville G, Guay C, Guay B, Morin CM. Hypnotic taper with or without self-help treatment of insomnia: a randomized clinical trial. J Consult Clin Psychol 2007; 75:325.</a></li><li><a class="nounderline abstract_t">Baillargeon L, Landreville P, Verreault R, et al. Discontinuation of benzodiazepines among older insomniac adults treated with cognitive-behavioural therapy combined with gradual tapering: a randomized trial. CMAJ 2003; 169:1015.</a></li><li><a class="nounderline abstract_t">Takaesu Y, Utsumi T, Okajima I, et al. Psychosocial intervention for discontinuing benzodiazepine hypnotics in patients with chronic insomnia: A systematic review and meta-analysis. Sleep Med Rev 2019; 48:101214.</a></li><li><a class="nounderline abstract_t">McCrae CS, Curtis AF, Williams JM, et al. Efficacy of brief behavioral treatment for insomnia in older adults: examination of sleep, mood, and cognitive outcomes. Sleep Med 2018; 51:153.</a></li><li><a class="nounderline abstract_t">Buysse DJ, Germain A, Moul DE, et al. Efficacy of brief behavioral treatment for chronic insomnia in older adults. Arch Intern Med 2011; 171:887.</a></li><li><a class="nounderline abstract_t">Okajima I, Akitomi J, Kajiyama I, et al. Effects of a Tailored Brief Behavioral Therapy Application on Insomnia Severity and Social Disabilities Among Workers With Insomnia in Japan: A Randomized Clinical Trial. JAMA Netw Open 2020; 3:e202775.</a></li><li><a class="nounderline abstract_t">Maguen S, Gloria R, Huggins J, et al. Brief behavioral treatment for insomnia improves psychosocial functioning in veterans: results from a randomized controlled trial. Sleep 2021; 44.</a></li><li><a class="nounderline abstract_t">McLaren DM, Evans J, Baylan S, et al. The effectiveness of the behavioural components of cognitive behavioural therapy for insomnia in older adults: A systematic review. J Sleep Res 2023; 32:e13843.</a></li><li><a class="nounderline abstract_t">Kyle SD, Siriwardena AN, Espie CA, et al. Clinical and cost-effectiveness of nurse-delivered sleep restriction therapy for insomnia in primary care (HABIT): a pragmatic, superiority, open-label, randomised controlled trial. Lancet 2023; 402:975.</a></li></ol></div><div id="topicVersionRevision">Topic 97869 Version 15.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16376125" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Emerging research on the treatment and etiology of secondary or comorbid insomnia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16268373" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : National Institutes of Health State of the Science Conference statement on Manifestations and Management of Chronic Insomnia in Adults, June 13-15, 2005.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16268373" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : National Institutes of Health State of the Science Conference statement on Manifestations and Management of Chronic Insomnia in Adults, June 13-15, 2005.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16268373" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : National Institutes of Health State of the Science Conference statement on Manifestations and Management of Chronic Insomnia in Adults, June 13-15, 2005.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16268373" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : National Institutes of Health State of the Science Conference statement on Manifestations and Management of Chronic Insomnia in Adults, June 13-15, 2005.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31856367" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : The European Academy for Cognitive Behavioural Therapy for Insomnia: An initiative of the European Insomnia Network to promote implementation and dissemination of treatment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23842011" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Patient preference for psychological vs pharmacologic treatment of psychiatric disorders: a meta-analytic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28314434" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Acceptability of Medication and Nonmedication Treatment for Insomnia Among Female Veterans: Effects of Age, Insomnia Severity, and Psychiatric Symptoms.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12879147" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Hospitalized patients' preference in the treatment of insomnia: pharmacological versus non-pharmacological.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7185792" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : A two process model of sleep regulation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3563247" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Treatment of chronic insomnia by restriction of time in bed.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32421814" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Isolating the role of time in bed restriction in the treatment of insomnia: a randomized, controlled, dismantling trial comparing sleep restriction therapy with time in bed regularization.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10617176" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Nonpharmacologic treatment of chronic insomnia. An American Academy of Sleep Medicine review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10617175" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Practice parameters for the nonpharmacologic treatment of chronic insomnia. An American Academy of Sleep Medicine report. Standards of Practice Committee of the American Academy of Sleep Medicine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22294820" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : The consensus sleep diary: standardizing prospective sleep self-monitoring.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22294820" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : The consensus sleep diary: standardizing prospective sleep self-monitoring.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9554225" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Insomnia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12927121" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Use of sleep hygiene in the treatment of insomnia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12927121" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Use of sleep hygiene in the treatment of insomnia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32992228" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Does cognitive behaviour therapy for insomnia reduce repetitive negative thinking and sleep-related worry beliefs? A systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7104246" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Progressive relaxation, EMG biofeedback and biofeedback placebo in the treatment of sleep-onset insomnia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22975073" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Improving sleep with mindfulness and acceptance: a metacognitive model of insomnia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28647747" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Comparing the Effects of Mindfulness-Based Cognitive Therapy and Sleep Psycho-Education with Exercise on Chronic Insomnia: A Randomised Controlled Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18853708" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Clinical guideline for the evaluation and management of chronic insomnia in adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20813762" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27136449" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Management of Chronic Insomnia Disorder in Adults: A Clinical Practice Guideline From the American College of Physicians.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27136619" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Psychological and Behavioral Interventions for Managing Insomnia Disorder: An Evidence Report for a Clinical Practice Guideline by the American College of Physicians.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28875581" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : European guideline for the diagnosis and treatment of insomnia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10086433" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Behavioral and pharmacological therapies for late-life insomnia: a randomized controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28364426" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Long-Term Maintenance of Therapeutic Gains Associated With Cognitive-Behavioral Therapy for Insomnia Delivered Alone or Combined With Zolpidem.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17326546" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Dose-response effects of cognitive-behavioral insomnia therapy: a randomized clinical trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24892895" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Cognitive and behavioural therapy for insomnia (CBT-I) in psychiatric populations: a systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26147487" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Cognitive Behavioral Therapy for Insomnia Comorbid With Psychiatric and Medical Conditions: A Meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22654199" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Dismantling multicomponent behavioral treatment for insomnia in older adults: a randomized controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : A meta-analysis on the treatment effectiveness of cognitive behavioral therapy for primary insomnia</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22631616" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Comparative effectiveness of cognitive behavioral therapy for insomnia: a systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28392168" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Cognitive and behavioral therapies in the treatment of insomnia: A meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33164741" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Behavioral and psychological treatments for chronic insomnia disorder in adults: an American Academy of Sleep Medicine systematic review, meta-analysis, and GRADE assessment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33164742" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Behavioral and psychological treatments for chronic insomnia disorder in adults: an American Academy of Sleep Medicine clinical practice guideline.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35653951" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Effects of cognitive behavioral therapy for insomnia (CBT-I) on quality of life: A systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32658298" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Telemedicine versus face-to-face delivery of cognitive behavioral therapy for insomnia: a randomized controlled noninferiority trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34428360" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Randomized Noninferiority Trial of Telehealth Delivery of Cognitive Behavioral Treatment of Insomnia Compared to In-Person Care.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24931811" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : A meta-analysis of group cognitive behavioral therapy for insomnia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23450712" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Randomized controlled trial of telephone-delivered cognitive behavioral therapy for chronic insomnia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15301650" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Cognitive-behavioral therapy for insomnia: comparison of individual therapy, group therapy, and telephone consultations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19544758" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Logging on for better sleep: RCT of the effectiveness of online treatment for insomnia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19581560" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Efficacy of an Internet-based behavioral intervention for adults with insomnia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24001364" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Guided Internet-delivered cognitive behavioural treatment for insomnia: a randomized trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24461370" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Web- vs. telehealth-based delivery of cognitive behavioral therapy for insomnia: a randomized controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27902836" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Effect of a Web-Based Cognitive Behavior Therapy for Insomnia Intervention With 1-Year Follow-up: A Randomized Clinical Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26615572" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Efficacy of internet-delivered cognitive-behavioral therapy for insomnia - A systematic review and meta-analysis of randomized controlled trials.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29747706" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Does online insomnia treatment reduce depressive symptoms? A randomized controlled trial in individuals with both insomnia and depressive symptoms.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29792241" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Efficacy of digital CBT for insomnia to reduce depression across demographic groups: a randomized trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30264137" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Effect of Digital Cognitive Behavioral Therapy for Insomnia on Health, Psychological Well-being, and Sleep-Related Quality of Life: A Randomized Clinical Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35442432" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Effect of Culturally Tailored, Internet-Delivered Cognitive Behavioral Therapy for Insomnia in Black Women: A Randomized Clinical Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20041590" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : "Stepped care": a health technology solution for delivering cognitive behavioral therapy as a first line insomnia treatment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26414893" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Guided Online or Face-to-Face Cognitive Behavioral Treatment for Insomnia: A Randomized Wait-List Controlled Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1987812" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : The APA Task Force report on benzodiazepine dependence, toxicity, and abuse.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36738299" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Deprescribing long-term use of benzodiazepines in primary care practice: where to next?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14754783" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Randomized clinical trial of supervised tapering and cognitive behavior therapy to facilitate benzodiazepine discontinuation in older adults with chronic insomnia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17469890" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Hypnotic taper with or without self-help treatment of insomnia: a randomized clinical trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14609970" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Discontinuation of benzodiazepines among older insomniac adults treated with cognitive-behavioural therapy combined with gradual tapering: a randomized trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31648145" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Psychosocial intervention for discontinuing benzodiazepine hypnotics in patients with chronic insomnia: A systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30195661" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Efficacy of brief behavioral treatment for insomnia in older adults: examination of sleep, mood, and cognitive outcomes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21263078" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Efficacy of brief behavioral treatment for chronic insomnia in older adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32286659" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Effects of a Tailored Brief Behavioral Therapy Application on Insomnia Severity and Social Disabilities Among Workers With Insomnia in Japan: A Randomized Clinical Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33022048" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Brief behavioral treatment for insomnia improves psychosocial functioning in veterans: results from a randomized controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36802110" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : The effectiveness of the behavioural components of cognitive behavioural therapy for insomnia in older adults: A systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37573859" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Clinical and cost-effectiveness of nurse-delivered sleep restriction therapy for insomnia in primary care (HABIT): a pragmatic, superiority, open-label, randomised controlled trial.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
